← Eichor
Condition: Sickle Cells Patients Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Sickle Cells Patients

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Ultrasound Acute Chest Syndrome Sickle Cell Disease
NA · 1 location(s) · Indiana University · NCT06880679Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT03685721Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT03279094Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET
Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT05583721Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia
NA · 5 location(s) · University of Pittsburgh · NCT04109820Study of Vitamin B12 Metabolism in Children With Sickle Cell Disease Exposed to MEOPA
Phase N/A · 1 location(s) · CHU de Reims · NCT06581900RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
Phase N/A · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06213402Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Phase 2 · 4 location(s) · New York Medical College · NCT02675959RH Genotype Matched RBC Transfusions
Phase 1/Phase 2 · 1 location(s) · Children's Hospital of Philadelphia · NCT04156893Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cell
Phase 1/Phase 2 · 2 location(s) · Mark Walters, MD · NCT04774536Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Si
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT06944067High-flow Oxygen for Vaso-occlusive Pain Crisis
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT03976180A Real-World Registry of Chronic Wounds and Ulcers
Phase N/A · 1 location(s) · U.S. Wound Registry · NCT02280733Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease
NA · 1 location(s) · University of Pennsylvania · NCT07316478Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain
NA · 1 location(s) · Louisiana State University Health Sciences Center in New Orl · NCT06773715CS-206 in Patients With Sickle Cell Disease
EARLY_Phase 1 · 1 location(s) · CorrectSequence Therapeutics Co., Ltd · NCT06565026Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimer
Phase 1/Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT04008368Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Phase 4 · 31 location(s) · Novartis Pharmaceuticals · NCT04657822Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Cr
NA · 1 location(s) · University of Maryland, Baltimore · NCT06184126Pediatric -Adult Care Transition Program of Patients With Sickle Cell Disease
NA · 8 location(s) · Hospices Civils de Lyon · NCT03786549Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering Fro
NA · 1 location(s) · Emory University · NCT07090668Impact of Regional Anesthesia on Inflammatory Mechanisms During Vaso-occlusive Crisis in Sickle Cell Patients
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT07001189Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Phase N/A · 9 location(s) · RTI International · NCT06385886Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
Phase 2 · 1 location(s) · Suvankar Majumdar · NCT06635902A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patien
Phase 2 · 9 location(s) · Forma Therapeutics, Inc. · NCT05953584A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Phase 1/Phase 2 · 9 location(s) · Novartis Pharmaceuticals · NCT06546670T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Phase 1/Phase 2 · 1 location(s) · Paul Szabolcs · NCT03653338Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease
Phase 3 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06818266Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT07000747
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.